Cargando…
Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase
Schizophrenia is one of the leading disorders causing impairment in society. Therefore, it is crucial to review evidence-based treatment approaches which are both effective and causing minimum side effects. In this paper, treatment recommendations for first episode schizophrenia, patients in acute p...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Noro-Psikiyatri Arsivi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498812/ https://www.ncbi.nlm.nih.gov/pubmed/34658631 http://dx.doi.org/10.29399/npa.27441 |
_version_ | 1784580249076367360 |
---|---|
author | KIRLI, Umut ALPTEKİN, Köksal |
author_facet | KIRLI, Umut ALPTEKİN, Köksal |
author_sort | KIRLI, Umut |
collection | PubMed |
description | Schizophrenia is one of the leading disorders causing impairment in society. Therefore, it is crucial to review evidence-based treatment approaches which are both effective and causing minimum side effects. In this paper, treatment recommendations for first episode schizophrenia, patients in acute phase with a history of multiple episodes, and patients in the maintenance phase will be discussed in light of the Psychiatric Association of Turkey Guideline for Treatment of Schizophrenia, other recent national and international guidelines as well as expert consensus reports in the literature. Finally, practical considerations will be suggested. |
format | Online Article Text |
id | pubmed-8498812 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Noro-Psikiyatri Arsivi |
record_format | MEDLINE/PubMed |
spelling | pubmed-84988122021-10-14 Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase KIRLI, Umut ALPTEKİN, Köksal Noro Psikiyatr Ars Review Schizophrenia is one of the leading disorders causing impairment in society. Therefore, it is crucial to review evidence-based treatment approaches which are both effective and causing minimum side effects. In this paper, treatment recommendations for first episode schizophrenia, patients in acute phase with a history of multiple episodes, and patients in the maintenance phase will be discussed in light of the Psychiatric Association of Turkey Guideline for Treatment of Schizophrenia, other recent national and international guidelines as well as expert consensus reports in the literature. Finally, practical considerations will be suggested. Noro-Psikiyatri Arsivi 2021-09-20 /pmc/articles/PMC8498812/ /pubmed/34658631 http://dx.doi.org/10.29399/npa.27441 Text en Copyright: © 2021 Turkish Neuropsychiatric Society https://creativecommons.org/licenses/by-nc-sa/3.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review KIRLI, Umut ALPTEKİN, Köksal Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase |
title | Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase |
title_full | Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase |
title_fullStr | Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase |
title_full_unstemmed | Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase |
title_short | Pharmacotherapy of Schizophrenia in Acute and Maintenance Phase |
title_sort | pharmacotherapy of schizophrenia in acute and maintenance phase |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498812/ https://www.ncbi.nlm.nih.gov/pubmed/34658631 http://dx.doi.org/10.29399/npa.27441 |
work_keys_str_mv | AT kirliumut pharmacotherapyofschizophreniainacuteandmaintenancephase AT alptekinkoksal pharmacotherapyofschizophreniainacuteandmaintenancephase |